Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Empagliflozin/linagliptin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Empagliflozin 25mg / Linagliptin 5mg tablets
0601023AYAAABAB
|
Empagliflozin/linagliptin | Empagliflozin/linagliptin | Endocrine System | 1,356 |
|
Empagliflozin 10mg / Linagliptin 5mg tablets
0601023AYAAAAAA
|
Empagliflozin/linagliptin | Empagliflozin/linagliptin | Endocrine System | 868 |
|
Glyxambi 10mg/5mg tablets
0601023AYBBAAAA
|
Glyxambi | Empagliflozin/linagliptin | Endocrine System | 41 |
|
Glyxambi 25mg/5mg tablets
0601023AYBBABAB
|
Glyxambi | Empagliflozin/linagliptin | Endocrine System | 21 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.